Shocking statistics of India: one-third of Indian women and one-fifth of Indian men suffer from migraine. Approximately 38% of migraine patients need preventive therapy, but only 3%-13% currently use it . Therefore, The American Academy of Neurology (AAN) has published guideline for pharmacologic treatment for episodic migraine prevention in adults. This article gives a brief overview of the guideline.
Migraine is a primary headache disorder characterized by recurrent headaches that are moderate to severe. The annual years of healthy life lost per 100,000 people from migraine in India have increased by 11.4% since 1990. By studying 284 articles, the AAN has evidence-reviewed all the pharmacologic treatment used in current practice for migraine. Based on the review of the expert panel, AAP has given recommendations regarding pharmacologic therapies which are proven effective to prevent…
